Francois-Emery Cotte - Bristol-Myers Squibb

基本信息

浏览量：49

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 107 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

EE57 Cost-Effectiveness of Mavacamten for the Treatment of Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM) in France

FE Cotte,M Hurst, S Akarkoub, M Ho, J Vernon,L Chambry, V Vega,S Leproust

Value in Healthno. 12 (2024): S64

引用0浏览0引用

Clinical Benefit of Anti-Pd-(l)1 Immunotherapies in Advanced Cancer in France: a Population-Based Estimate from 2014 to 2021

V. Grumberg,F. -e. Cotte,E. Giroux-Leprieur,A. -f. Gaudin,C. Lebbe,I. Borget

ESMO Open（2024）

引用1浏览0WOS引用

EE204 Nationwide Extrapolation of Economic Impact of Therapeutic Innovation: A 10-Year Retrospective Budget Impact Model of Direct Oral Anticoagulants (DOAC) Introduction in France

C Guilmet, R Moreau,FE Cotte, H Lesage, C Marant Micallef,M Née, D. Guitard-Dehoux,M Belhassen,N Danchin

Value in Healthno. 12 (2024): S94

引用0浏览0引用

SA67 Health Care Resource Utilization and Associated Costs among Lower-Risk Myelodysplastic Syndrome Patients in France: Edelweiss Study

T. Comont,J. Fernandes,M. Chartier,F.E. Cotte, N. Pages,A. Panes,A. Schmidt, L. Webert, M. D.' Aveni-piney

Value in Healthno. 12 (2024): S627

引用0浏览0引用

EE137 Cost-Effectiveness Analysis of Neoadjuvant Nivolumab Plus Platinum-Based Chemotherapy (PDC) in Resectable Non-Small Cell Lung Cancer (NSCLC) in France: A Situation of Dominance

P Casabianca,J Carette,C Chouaid,M Harris,M Chartier, A Sun, B White,H Leleu,S Lucherini,FE Cotte

Value in Healthno. 12 (2024): S80-S81

引用0浏览0引用

EE155 Economic Burden of Obstructive Hypertrophic Cardiomyopathy in France

P. Charron, C. L. Zema,F. E. Cotte, A. Juban, A. Schmidt,T. Krause,M. Hurst, J. Gonzalez, J. N. Trochu

Value in Healthno. 12 (2023): S80-S80

引用0浏览0引用

PCR132 Correlation Between Quality of Life (qol) of Patients Treated with Nivolumab in Recurrent And/or Metastatic Squamous Cell Carcinoma of Head and Neck (R/M SCCHN) and Their Caregivers

K. Baumstarck,C. Even,V Grumberg, D. Schwartz, J. Lahaye,Y. Pointreau,P. Ceruse,E. Babin,J. Fayette,V Rondeau,F. E. Cotte, A. Govart,S. Salas,C. Le Tourneau

Value in Healthno. 12 (2023): S474-S474

引用0浏览0引用

Patients En Vie 5 Ans Après L’initiation De Nivolumab Dans Le Cancer Bronchique Non À Petites Cellules Métastatique : Caractéristiques, Prise En Charge Et Consommations De Soins

J.B. Assié,F.E. Cotté,D. Reynaud,A.F. Gaudin,V. Grumberg,R. Jolivel,B. Jouaneton,C. Chouaïd

Revue des Maladies Respiratoires Actualités（2023）

引用0浏览0引用

938P Nivolumab (nivo) in Recurrent And/or Metastatic Squamous Cell Carcinoma of Head and Neck (R/M SCCHN): Real-World Effectiveness, Quality of Life (qol) of Patients and Their Caregivers in France (pronihn Study)

C. Le Tourneau,C. Even,S. Salas,Y. Pointreau,P. Ceruse,E. Babin,J. Fayette,V. Rondeau,V. Grumberg,F-E. Cotte, A. Govart,K. Baumstarck,J. Guigay

Annals of Oncology (2023): S590-S590

引用0浏览0引用

1752P Clinical Benefit of Immunotherapies in Advanced Cancer in France: A Population-Based Estimate from 2014 to 2021

I. Borget,F-E. Cotté,E. Giroux-Leprieur,A-F. Gaudin,C. Lebbe,V. Grumberg

Annals of Oncology（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn